Evidence map›Paper›PMID 41134839›Full record

ArticlePloS one2025

YOLOv11-MFF: A multi-scale frequency-adaptive fusion network for enhanced CXR anomaly detection.

Li Guan, Ruting Zhang, Yi Zhao

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Li GuanDepartment of Smart Manufacturing, Industrial Perception and Intelligent Manufacturing Equipment Engineering Research Center of Jiangsu Province, Nanjing Vocational University of Industry Technology, Nanjing, Jiangsu, China.ORCID https://orcid.org/0009-0007-3595-1585
Ruting ZhangDepartment of Radiotherapy, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
Yi ZhaoMechanical and Electronic Systems Engineering Course, Graduate School of Engineering, Takushoku University, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chest X-ray (CXR) represents one of the most widely utilized clinical diagnostic tools for thoracic diseases. Nevertheless, computer-aided diagnosis based on chest radiographs still faces considerable challenges in anomaly detection. Certain lesions in CXRs exhibit subtle radiographic characteristics with ambiguous boundaries, low pixel occupancy, and weak contrast. While existing studies primarily focus on improving multi-scale feature fusion, they frequently overlook complications arising from background noise and varied lesion morphology. This study introduces YOLOv11-MFF, an enhanced YOLOv11 network with three key innovations. Specifically, a novel Frequency-Adaptive Hybrid Gate (FAHG) is developed to improve contrast differentiation between lesions and background. A Multi Scale Parallel Large Convolution (MSPLC) block is designed and integrated with the original C3k2 module to expand receptive fields and enhance long-range modeling capacity. Furthermore, a Feature Fusion module (FF) is introduced to reinforce target-relevant feature representation through channel-wise modulation via weight recalibration mechanisms. Benefiting from these advancements, the network achieves significant improvements in detecting multi-scale and overlapping lesions. Experimental results on the public VinDr-CXR dataset demonstrate that YOLOv11-MFF outperforms state-of-the-art models, achieving a precision of 48.2%, recall of 42.5%, mAP@0.5 of 41.5%, and mAP@0.5:0.95 of 22.6%.

Indexed as

Neural Networks, ComputerRadiographic Image Interpretation, Computer-AssistedRadiography, ThoracicAlgorithmsHumans

Identifiers

PMID41134839
PMCPMC12551852

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.